UBS AM’s Dermira, Inc. DERM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-47,220
| Closed | -$716K | – | 2560 |
|
|
2019
Q4 | $716K | Sell |
47,220
-2,722
| -5% | -$23.5K | ﹤0.01% | 2085 |
|
|
2019
Q3 | $319K | Buy |
49,942
+7,444
| +18% | +$62.2K | ﹤0.01% | 2434 |
|
|
2019
Q2 | $406K | Buy |
42,498
+30,434
| +252% | +$328K | ﹤0.01% | 2302 |
|
|
2019
Q1 | $163K | Buy |
12,064
+1,200
| +11% | +$10K | ﹤0.01% | 2511 |
|
|
2018
Q4 | $78.1K | Sell |
10,864
-13,068
| -55% | -$143K | ﹤0.01% | 2540 |
|
|
2018
Q3 | $261K | Hold |
23,932
| – | – | ﹤0.01% | 2326 |
|
|
2018
Q2 | $220K | Buy |
23,932
+13,068
| +120% | +$122K | ﹤0.01% | 2438 |
|
|
2018
Q1 | $86.8K | Buy |
+10,864
| New | +$237K | ﹤0.01% | 2469 |
|
|
2017
Q1 | – | Sell |
-58
| Closed | -$2K | – | 2506 |
|
|
2016
Q4 | $2K | Sell |
58
-7,906
| -99% | -$255K | ﹤0.01% | 2456 |
|
|
2016
Q3 | $269K | Buy |
+7,964
| New | +$256K | ﹤0.01% | 2324 |
|
UBS AM's DERM Position: Q1 2020 in Review
UBS AM sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 47,220 shares — an estimated $716K sold.
UBS AM first reported a position in DERM in Q3 2016 and held it in 10 quarters. The position peaked at $716K in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.
- UBS AM reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
- UBS AM sold 47,220 Dermira, Inc. shares in Q1 2020, an estimated $716K.
- UBS AM first reported a position in Dermira, Inc. in Q3 2016 and held it in 10 quarters.
- UBS AM's Dermira, Inc. position peaked at $716K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.
Based on UBS AM's 13F filing for Q1 2020, filed 15 May 2020.